278 related articles for article (PubMed ID: 10971444)
1. Growth hormone deficiency and replacement in elderly hypopituitary adults. KIMS Study Group and the KIMS International Board. Pharmacia and Upjohn International Metabolic Database.
Monson JP; Abs R; Bengtsson BA; Bennmarker H; Feldt-Rasmussen U; Hernberg-Stâhl E; Thorén M; Westberg B; Wilton P; Wüster C
Clin Endocrinol (Oxf); 2000 Sep; 53(3):281-9. PubMed ID: 10971444
[TBL] [Abstract][Full Text] [Related]
2. Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults.
Feldt-Rasmussen U; Wilton P; Jonsson P; ;
Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S51-8. PubMed ID: 15135778
[TBL] [Abstract][Full Text] [Related]
3. Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults - a KIMS database analysis.
Abs R; Feldt-Rasmussen U; Mattsson AF; Monson JP; Bengtsson BA; Góth MI; Wilton P; Koltowska-Häggström M
Eur J Endocrinol; 2006 Jul; 155(1):79-90. PubMed ID: 16793953
[TBL] [Abstract][Full Text] [Related]
4. The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults. KIMS Study Group and the KIMS International Board.
Bengtsson BA; Abs R; Bennmarker H; Monson JP; Feldt-Rasmussen U; Hernberg-Stahl E; Westberg B; Wilton P; Wüster C
J Clin Endocrinol Metab; 1999 Nov; 84(11):3929-35. PubMed ID: 10566630
[TBL] [Abstract][Full Text] [Related]
5. GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety.
Abs R; Bengtsson BA; Hernberg-Stâhl E; Monson JP; Tauber JP; Wilton P; Wüster C
Clin Endocrinol (Oxf); 1999 Jun; 50(6):703-13. PubMed ID: 10468941
[TBL] [Abstract][Full Text] [Related]
6. Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study.
Florakis D; Hung V; Kaltsas G; Coyte D; Jenkins PJ; Chew SL; Grossman AB; Besser GM; Monson JP
Clin Endocrinol (Oxf); 2000 Oct; 53(4):453-9. PubMed ID: 11012570
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone (GH) replacement therapy in GH deficient adults: predictors of one-year metabolic and clinical response.
Svensson J; Finer N; Bouloux P; Bevan J; Jonsson B; Mattsson AF; Lundberg M; Harris PE; Koltowska-Häggström M; Monson JP;
Growth Horm IGF Res; 2007 Feb; 17(1):67-76. PubMed ID: 17223598
[TBL] [Abstract][Full Text] [Related]
8. Baseline characteristics and response to 2 years of growth hormone (GH) replacement of hypopituitary patients with GH deficiency due to adult-onset craniopharyngioma in comparison with patients with nonfunctioning pituitary adenoma: data from KIMS (Pfizer International Metabolic Database).
Verhelst J; Kendall-Taylor P; Erfurth EM; Price DA; Geffner M; Koltowska-Häggström M; Jönsson PJ; Wilton P; Abs R
J Clin Endocrinol Metab; 2005 Aug; 90(8):4636-43. PubMed ID: 15928246
[TBL] [Abstract][Full Text] [Related]
9. Aspects of growth hormone (GH) replacement in elderly patients with GH deficiency: data from KIMS.
Monson JP; Jönsson P
Horm Res; 2003; 60(Suppl 1):112-20. PubMed ID: 12955027
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone (GH) replacement decreases serum total and LDL-cholesterol in hypopituitary patients on maintenance HMG CoA reductase inhibitor (statin) therapy.
Monson JP; Jönsson P; Koltowska-Häggström M; Kourides I
Clin Endocrinol (Oxf); 2007 Oct; 67(4):623-8. PubMed ID: 17581260
[TBL] [Abstract][Full Text] [Related]
11. Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database.
Abs R; Mattsson AF; Bengtsson BA; Feldt-Rasmussen U; Góth MI; Koltowska-Häggström M; Monson JP; Verhelst J; Wilton P;
Growth Horm IGF Res; 2005 Oct; 15(5):349-59. PubMed ID: 16168692
[TBL] [Abstract][Full Text] [Related]
12. Long-term experience with GH replacement therapy: efficacy and safety.
Monson JP
Eur J Endocrinol; 2003 Apr; 148 Suppl 2():S9-14. PubMed ID: 12670295
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone deficiency and replacement in hypopituitary patients previously treated for acromegaly or Cushing's disease.
Feldt-Rasmussen U; Abs R; Bengtsson BA; Bennmarker H; Bramnert M; Hernberg-Ståhl E; Monson JP; Westberg B; Wilton P; Wüster C;
Eur J Endocrinol; 2002 Jan; 146(1):67-74. PubMed ID: 11751070
[TBL] [Abstract][Full Text] [Related]
14. The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients.
Filipsson H; Monson JP; Koltowska-Häggström M; Mattsson A; Johannsson G
J Clin Endocrinol Metab; 2006 Oct; 91(10):3954-61. PubMed ID: 16895963
[TBL] [Abstract][Full Text] [Related]
15. Elevated leptin concentrations in growth hormone-deficient hypopituitary adults.
al-Shoumer KA; Anyaoku V; Richmond W; Johnston DG
Clin Endocrinol (Oxf); 1997 Aug; 47(2):153-9. PubMed ID: 9302387
[TBL] [Abstract][Full Text] [Related]
16. Replacement treatment with biosynthetic human growth hormone in growth hormone-deficient hypopituitary adults.
Beshyah SA; Freemantle C; Shahi M; Anyaoku V; Merson S; Lynch S; Skinner E; Sharp P; Foale R; Johnston DG
Clin Endocrinol (Oxf); 1995 Jan; 42(1):73-84. PubMed ID: 7889635
[TBL] [Abstract][Full Text] [Related]
17. Dose titration and patient selection increases the efficacy of GH replacement in severely GH deficient adults.
Murray RD; Skillicorn CJ; Howell SJ; Lissett CA; Rahim A; Shalet SM
Clin Endocrinol (Oxf); 1999 Jun; 50(6):749-57. PubMed ID: 10468947
[TBL] [Abstract][Full Text] [Related]
18. Coronary risk in growth hormone deficient hypopituitary adults: increased predicted risk is due largely to lipid profile abnormalities.
Abdu TA; Neary R; Elhadd TA; Akber M; Clayton RN
Clin Endocrinol (Oxf); 2001 Aug; 55(2):209-16. PubMed ID: 11531927
[TBL] [Abstract][Full Text] [Related]
19. Sheehan's syndrome: baseline characteristics and effect of 2 years of growth hormone replacement therapy in 91 patients in KIMS - Pfizer International Metabolic Database.
Kelestimur F; Jonsson P; Molvalilar S; Gomez JM; Auernhammer CJ; Colak R; Koltowska-Häggström M; Goth MI
Eur J Endocrinol; 2005 Apr; 152(4):581-7. PubMed ID: 15817914
[TBL] [Abstract][Full Text] [Related]
20. Health-related quality of life and IGF-1 in GH-deficient adult patients on GH replacement therapy: analysis of the German KIMS data and the Study of Health in Pomerania.
Moock J; Albrecht C; Friedrich N; Völzke H; Nauck M; Koltowska-Haggström M; Kohlmann T; Wallaschofski H
Eur J Endocrinol; 2009 Jan; 160(1):17-24. PubMed ID: 18974232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
